TREATMENT OF COVID-19 PATIENTS:

ADVANCED HEMODYNAMIC MONITORING PLAYS A MAJOR ROLE 

CHALLENGE:

• Complex interaction of respiratory and cardiovascular factors

• Conservative / restrictive fluid management vs. hypovolemia (too dry vs. too wet)

• Preventing quick patient deterioration & progression of symptoms

MEDICAL NEED:

• Efficient management of complex interaction of respiration, right ventricular function and other cardiovascular factors

• Early hemodynamic monitoring from first examination to cope with “therapeutic conflict”¹ of  too much vs. too little fluid

• Daily examination due to quick change of hemodynamic status:
  • Functional hemodynamic test at bedside
  • Individualized therapy
  • Precise & real-time hemodynamic monitoring device for long treatment periods (>10 days)

SOLUTION: CNAP^® HD

• Quick & accurate

CNAP^® HD provides real-time monitoring of advanced hemodynamics and guidance to fluid management (BP, SV, CO, PPV/SVV) using a simple finger sensor. Maintaining continuous control of MAP >65 mmHg is essential to ensure sufficient oxygen supply. Further, CNAP^® HD allows for accurate feedback on functional hemodynamic tests to direct volume expansion regardless of the patient´s ventilation (spontaneous breathing, noninvasive or mechanical)

• Noninvasive & easy to use

The special design of CNAP^® HD allows for quick and easy setup without any burden for the patient. Its simple application relieves healthcare professionals in their daily routine.

• Early recognition and preventing deterioration

Implementing conservative fluid management while preventing from hypovolemia is key in the management of COVID-19 patients. As the progression of symptoms can change quickly, a daily hemodynamic assessment is recommended. CNAP^® HD supports healthcare professionals in educated decision making through accurate real-time feedback during functional hemodynamic tests even at bedside.